NCT05399212View on ClinicalTrials.gov

Composition for Treating Spermatogenesis and Semen Disorders / FPT-20

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions
Spermatogenesis and Semen Disorders
Interventions
DRUG

FPT-20

FPT-20 should be used regularly, the daily maintenance dose is 1 tablet once a day(\>6 to 12 months) until the therapeutic purpose is achieved.

Trial Locations (2)

700000

Saigon Biopharma Company Limited, Hồ Chí Minh

19801-6601

Saigon Biopharma LLC, Wilmington

All Listed Sponsors
collaborator

TRAN MINH DUC, MD

UNKNOWN

lead

Trieu, Nguyen Thi, M.D.

INDIV

NCT05399212 - Composition for Treating Spermatogenesis and Semen Disorders / FPT-20 | Biotech Hunter | Biotech Hunter